H. Stewart Parker

Performance

Overall performance
4.0

Performance over holding periods
4.0
30 days 90 days 120 days
Average return 17% 8.2% 15.1%
Success rate 63% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director Neose Technologies Inc May 3, 2005 -
Director Armata Pharmaceuticals Inc May 9, 2019 -
Independent Director Achieve Life Sciences Inc March 23, 2010 -
Independent Director Sangamo Therapeutics Inc June 17, 2014 -

H. Stewart Parker's trades of Sangamo Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-06-03 2022-06-01 B Purchase
10,217 +32.4%
262.34
US$4,382,600
10,217 +32.4% 262.34 US$4,382,600
2020-03-19 2020-03-18 B Purchase
19,512 -29.8%
333.73
US$2,824,356
19,512 -29.8% 333.73 US$2,824,356
2006-09-05 2006-09-05 B Purchase
23,883 -4.7%
52.74
US$3,921,264
23,883 -4.7% 52.74 US$3,921,264
2006-09-05 2006-09-05 B Purchase
200 +0.9%
1.99
US$398
200 +0.9% 1.99 US$398
2006-09-05 2006-09-05 B Purchase
1,300 +6.1%
1.95
US$2,535
1,300 +6.1% 1.95 US$2,535
2006-09-05 2006-09-05 B Purchase
60 +0.3%
1.91
US$115
60 +0.3% 1.91 US$115